Week 3- Diabetes Flashcards
Canagliflozin Brand name
Invokana
Canagliflozin Class
SGLT-2i
Canagliflozin Dosage forms
Oral tablet
Canagliflozin Indication
T2DM
Canagliflozin BBW
Amputation of lower limbs
Canagliflozin CI’s
Severe renal impairment
Canagliflozin Dose Adjustments
Renal
Canagliflozin SE (3)
Hyperkalemia
GU infection
Renal insufficiency
Dapagliflozin Brand Name
Farxiga
Dapagliflozin Class
SLGT-2i
Dapagliflozin dosage forms
Oral tablet
Dapagliflozin Indication
T2DM
HF
Dapagliflozin dose adjustments
Renal
Dapagliflozin CI
Severe renal impairment
Dapagliflozin SE
No significant
Dulaglutide Brand name
Trulicity
Dulaglutide Class
GLP-1
Dulaglutide MOA
glucose-dependent insulin secretion and slows gastric emptying
Dulaglutide indication
T2DM
Dulaglutide BBW
Risk of thyroid cancers
Dulaglutide CI
Family H/O medullary thyroid carcinoma
Dulaglutide dosage form
Pen injector, SC
Dulaglutide SE (3)
Nausea
Diarrhea
Weight loss
Dulaglutide Max dose
4.5 mg once weekly
Exenatide Brand name
Byetta
Bydureon
Exenatide class
GLP-1
Exenatide dosage forms
SC Solution for injection
SC Suspension for injection
Exenatide indication
T2DM
Exenatide MOA
Glucose dependent insulin secretion and slows gastric emptying
Exenatide dose adjustments
Renal
Exenatide BBW
Thyroid C- cell tumors (bydureon)
Exenatide SE (4)
Hypoglycemia
Nausea
Diarrhea
Injection site reaction
Liraglutide Brand name
Victoza
Saxenda
Liraglutide drug class
GLP-1
Liraglutide dosage forms
Solution, pen injector
Liraglutide MOA
increases glucose-dependent insulin secretion, decreases inappropriate glucagon secretion, slows gastric emptying, and increases satiety.
Liraglutide Indication
T2DM
Weight loss
Liraglutide BBW
Increased risk of thyroid cancer
Liraglutide CI
multiple endocrine neoplasia syndrome type 2
family history of medullary thyroid carcinoma
Liraglutide SE (4)
Nausea
Diarrhea
Vomiting
Hypoglycemia
Liraglutide max dose (victoza)
1.8 mg/day
Glimepiride Brand name
Amaryl
Glimepiride Class
2nd gen sulfonylurea
Glimepiride dosage forms
Oral tablet
Glimepiride Indication
T2DM
Glimepiride max dose
8 mg/day
Glimepiride MOA
Enhances insulin secretion from pancreatic beta cells
Glimepiride dose adjustments
Renal
Glimepiride CI
Diabetic Ketoacidosis